Hep Par 1 expression in carcinoma of the cervix: Implications for diagnosis and prognosis

Journal of Clinical Pathology

Volumn 57, Issue 1, 2004, Pages 48-53

  Thamboo, T P ^a   Wee, A ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; CHROMOGRANIN; HEP PAR 1 PROTEIN; MARKER; PROTEIN; SYNAPTOPHYSIN; UNCLASSIFIED DRUG;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER INVASION; CARCINOMA; CARCINOMA IN SITU; CARDIOVASCULAR SYSTEM; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENDOMETRIUM; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; LARGE CELL CARCINOMA; NEUROENDOCRINE CARCINOMA; NEUROENDOCRINE DISEASE; NEUROENDOCRINE SYSTEM; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CARCINOMA;

ADENOCARCINOMA; ADULT; AGED; ALPHA-FETOPROTEINS; ANTIBODIES, MONOCLONAL; CARCINOMA IN SITU; CARCINOMA, SQUAMOUS CELL; CHROMOGRANINS; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; MIDDLE AGED; NEOPLASM PROTEINS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS;

EID: 0347755443     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.57.1.48     Document Type: Article

References (35)

1. Wennerberg AE, Nalesnik MA, Coleman WB. Hepatocyte Paraffin 1: a monoclonal antibody that reacts with hepatocytes and can be used for differential diagnosis of hepatic tumors. Am J Pathol 1993;143:1050-4.
2. Minervini MI, Demetris AJ, Lee RG, et al. Utilization of hepatocyte-specific antibody in the immunocytochemical evaluation of liver tumors. Mod Pathol 1997;10:686-92.
3. Leong AS-Y, Sormunen RT, Tsui WMS, et al. Hep Par 1 and selected antibodies in the immunohistological distinction of hepatocellular carcinoma from cholangiocarcinoma, combined tumours and metastatic carcinoma. Histopathology 1998;33:318-24.
4. Kumagai I, Masuda T, Sato S-I, et al. Immunoreactivity to monoclonal antibody, Hep Par 1, in human hepatocellular carcinomas according to histopathological grade and histological pattern. Hepatol Res 2001;20:312-19.
5. Zimmerman RL, Burke MA, Young NA, et al. Diagnostic value of hepatocyte paraffin 1 antibody to discriminate hepatocellular carcinoma from metastatic carcinoma in fine-needle aspiration biopsies of the liver Cancer 2001;93:288-91.
6. Siddiqui MT, Saboorian MH, Gokaslan ST, et al. Diagnostic utility of the HepPar1 antibody to differentiate hepatocellular carcinoma from metastatic carcinoma in fine-needle aspiration samples. Cancer 2002;96:49-52.
7. Morrison C, Marsh Jr W, Frankel WL. A comparison of CD10 to pCEA, MOC-31 and Hepatocyte for the distinction of malignant tumors in the liver. Mod Pathol 2002;15:1279-87.
8. Fan Z, van de Rijn M, Montgomery K, et al. Hep Par 1 antibody stoin for the differential diagnosis of hepatocellular carcinoma: 676 tumors tested using tissue microarrays and conventional tissue sections. Mod Pathol 2003;16:137-44.
9. Chu PG, Ishizawa S, Wu E, et al. Hepatocyte antigen as a marker of hepatocellular carcinoma. An immunohistochemical comparison to carcinoembryonic antigen, CD10 and alpha-fetoprotein. Am J Surg Pathol 2002;26:978-88.
10. Lau SK, Prakash S, Geller SA, et al. Comparative immunohistochemical profile of hepatocellular carcinoma, cholangiocarcinoma and metastatic carcinoma. Hum Pathol 2002;33:1175-81.
11. Roberts CC, Colby TV, Batts KP. Carcinoma of the stomach with hepatocytic differentiation (hepatoid adenocarcinoma). Mayo Clin Proc 1997;72:1154-60.
12. Ishikura H, Kishimoto T, Andachi H, et al. Gastrointestinal hepatoid adenocarcinoma: venous permeation and mimicry of hepatocellular carcinoma, a report of four cases. Histopathology 1997;31:47-54.
13. Li X, Zhang D, Le M. Histopathological and immunohistochemical studies in hepatoid adenocarcinomas of the stomach [In Chinese]. Zhonghua Bing Li Xue Za Zhi 1996;25:276-9.
14. Nagai E, Ueyama T, Yao T, et al. Hepatoid adenocarcinoma of the stomach. A clinicopathologic and immunohistochemical analysis. Cancer 1993;72:1827-35.
15. Ishikura H, Fukasawa Y, Ogasawara K, et al. An AFP-producing gastric carcinoma with features of hepatic differentiation. A case report. Cancer 1985;56:840-8.
16. Matsunou H, Konishi F, Jalal RE, et al. Alpha-fetoprotein-producing gastric carcinoma with enteroblastic differentiation. Cancer 1994;73:534-40.
17. Morinaga S, Takahashi Y. Primary hepatocellular carcinoma and hepatoid adenocarcinoma of the stomach with liver metastasis: an unusual association. Jpn J Clin Oncol 1996;26:258-63.
18. Rassidakis GZ, Delladetsima JK, Letsos SP, et al. Hepatoid adenocarcinoma of the stomach with extensive neuroendocrine differentiation and a coexisting carcinoid tumour. Histopathology 1998;33:186-8.
19. Maitra A, Murakata LA, Albores-Saavedra J. Immunoreactivity for hepatocyte paraffin 1 antibody in hepatoid adenocarcinomas of the gastrointestinal tract. Am J Clin Pathol 2001;115:689-94.
20. Hiroshima K, Iyoda A, Toyozaki T, et al. Alpha-fetoprotein-producing lung carcinoma: report of three cases. Pathol Int 2002;52:46-53.
21. Kimura N, Ghandur-Mnaymen L. An immunohistochemical study of keratin, carcinoembryonic antigen, human chorionic gonadotropin and alpha-fetoprotein in lung cancer. Tohoku J Exp Med 1985;145:23-38.
22. Yamamoto R, Ishikura H, Azuma M, et al. Alpha-fetoprotein production by a hepatoid adenocarcinoma of the uterus. J Clin Pathol 1996;49:420-2.
23. Hoshida Y, Nagakawa T, Mono S, et al. Hepatoid adenocarcinoma of the endometrium associated with alpha-fetoprotein production. Int J Gynecol Pathol 1996;15:266-9.
24. Toyoda H, Hirai T, Ischii E. Alpha-fetoprotein producing uterine corpus carcinoma: a hepatoid adenocarcinoma of the endometrium. Pathol Int 2000;50:847-52.
25. Adams SF, Yamada SD, Montag A, et al. An alpha-fetoprotein-producing hepatoid adenocarcinoma of the endometrium. Gynecol Oncol 2001;83:418-21.
26. Shintoku M, Kariya M, Shime H, et al. Adenocarcinoma of the uterine cervix with choriocarcinomatous and hepatoid differentiation: repart of a case. Int J Gynecol Pathol 2000;19:174-8.
27. Lopez-Beltran A, Luque RJ, Quintero A, et al. Hepatoid adenocarcinoma of the urinary bladder. Virchows Arch 2003;442:381-7.
28. Burgues O, Ferrer J, Navarro S, et al. Hepatoid adenocarcinoma of the urinary bladder. An unusual neoplasm. Virchows Arch 1999;435:71-5.
29. Yamada K, Fujioka Y, Ebihara Y, et al. Alpha-fetoprotein producing undifferentiated carcinoma of the bladder. J Urol 1994;152:958-60.
30. Wee A, Thamboo TP, Thomas A. Alpha-fetoprotein-producing liver carcinomas of primary extrahepatic origin: fine needle aspiration biopsy experience in 2 cases. Acta Cytol 2003;47:799-808.
31. Scully RE, Bonfiglio TA, Kurman RJ, et al. Histological typing of female genital tract tumours, 2nd ed. Berlin: Springer-Verlag, 1994 (World Health Organisation, International histological classification of tumours series).
32. Greene FL, Page DL, Fleming ID, et al. AJCC cancer staging handbook, 6th ed. New York: Springer Verlag, 2002.
33. Burghardt E, Baltzer J, Tulusan AH, et al. Results of surgical treatment of 1028 cervical cancers studied with volumetry. Cancer 1992;70:648-55.
34. Zaino RJ, Ward S, Delgado G, et al. Histopathologic predictors of the behavior of surgically treated stage IB squamous cell carcinoma of the cervix. A gynecologic oncology group study. Cancer 1992;69:1750-8.
35. Chavez-Blanco A, Taja-Chayeb L, Cetina L, et al. Neuroendocrine marker expression in cervical carcinomas of non-small cell type. Int J Gynecol Pathol 2002;21:368-74.